A

Anthem Biosciences Ltd
NSE:ANTHEM

Watchlist Manager
Anthem Biosciences Ltd
NSE:ANTHEM
Watchlist
Price: 598.7 INR 1.06% Market Closed
Market Cap: ₹336.2B

Operating Margin

31.6%
Current
Declining
by 0.4%
vs 3-y average of 32%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
31.6%
=
Operating Income
₹5.8B
/
Revenue
₹18.4B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
31.6%
=
Operating Income
₹5.8B
/
Revenue
₹18.4B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Anthem Biosciences Ltd
NSE:ANTHEM
332.7B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.4B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.5B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.7B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.3B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR
Loading...

Market Distribution

Higher than 90% of companies in India
Percentile
90th
Based on 5 437 companies
90th percentile
31.6%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Anthem Biosciences Ltd
Glance View

Anthem BioSciences Ltd. engages in contract research, development and manufacturing, and organization with fully integrated operations spanning across drug discovery, development and manufacturing. The company is headquartered in Bangalore, Karnataka and currently employs 2,062 full-time employees. The company went IPO on 2025-07-21. The firm helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and much more. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its product line includes human nutrition, animal health, and industrial products. Under human nutrition, it offers active pharmaceutical ingredients, dietary supplements, probiotics, and enzymes, among others.

ANTHEM Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
31.6%
=
Operating Income
₹5.8B
/
Revenue
₹18.4B
What is Anthem Biosciences Ltd's current Operating Margin?

The current Operating Margin for Anthem Biosciences Ltd is 31.6%, which is below its 3-year median of 32%.

How has Operating Margin changed over time?

Over the last 2 years, Anthem Biosciences Ltd’s Operating Margin has decreased from 34.6% to 31.6%. During this period, it reached a low of 29.8% on Mar 31, 2024 and a high of 34.6% on Mar 3, 2023.

Back to Top